Filing Details
- Accession Number:
- 0000898432-19-001253
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-10-16 16:33:12
- Reporting Period:
- 2019-10-16
- Accepted Time:
- 2019-10-16 16:33:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1706431 | Vir Biotechnology Inc. | VIR | () | AK |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1582681 | Alaska Permanent Fund Corp | 801 West 10Th Street Suite 302 Juneau AK 99801 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-10-16 | 2,222,222 | $0.00 | 5,555,556 | No | 4 | C | Indirect | By Yukon Investors, LLC |
| Common Stock | Acquisiton | 2019-10-16 | 666,667 | $0.00 | 5,555,556 | No | 4 | C | Indirect | By Altitude Life Science Ventures Fund II, L.P. and Altitude Life Science Ventures Side Fund II, L.P |
| Common Stock | Acquisiton | 2019-10-16 | 1,111,111 | $0.00 | 5,555,556 | No | 4 | C | Indirect | By Yukon Investors, LLC |
| Common Stock | Acquisiton | 2019-10-16 | 55,556 | $0.00 | 5,555,556 | No | 4 | C | Indirect | By Altitude Life Science Ventures Fund II, L.P. and Altitude Life Science Ventures Side Fund II, L.P |
| Common Stock | Acquisiton | 2019-10-16 | 1,500,000 | $20.00 | 5,555,556 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | By Yukon Investors, LLC |
| No | 4 | C | Indirect | By Altitude Life Science Ventures Fund II, L.P. and Altitude Life Science Ventures Side Fund II, L.P |
| No | 4 | C | Indirect | By Yukon Investors, LLC |
| No | 4 | C | Indirect | By Altitude Life Science Ventures Fund II, L.P. and Altitude Life Science Ventures Side Fund II, L.P |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A-1 convertible preferred stock | Disposition | 2019-10-16 | 2,222,222 | $0.00 | 2,222,222 | $0.00 |
| Common Stock | Series A-1 convertible preferred stock | Disposition | 2019-10-16 | 666,667 | $0.00 | 666,667 | $0.00 |
| Common Stock | Series B convertible preferred stock | Disposition | 2019-01-16 | 1,111,111 | $0.00 | 1,111,111 | $0.00 |
| Common Stock | Series B convertible preferred stock | Disposition | 2019-10-16 | 55,556 | $0.00 | 55,556 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- Upon closing of the issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration. There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock. On September 27, 2019, prior to the closing of the issuer's initial public offering, the issuer effected a 1-for-4.5 reverse stock split of its common stock and convertible preferred stock which is reflected in the numbers above.
Billionaire Hedge Funds
